Impax Laboratories to Present at Upcoming Investor Conferences on June 10
June 07 2010 - 11:00AM
Business Wire
Impax Laboratories, Inc. (Nasdaq: IPXL) today
announced that the Company will present at the Jefferies 2010
Global Life Sciences Conference on Thursday, June 10th, at 9:30
a.m. Eastern time. The conference will be held at The Grand Hyatt
Hotel, New York City.
The company will also present at the Needham 9th Annual
Healthcare Conference on Thursday, June 10th, at 3:20 p.m. Eastern
time. The conference will be held at The New York Palace Hotel, New
York City.
Individuals may listen to the live or an archived presentation
made at the conferences, which will be posted in the investor
relations section of the Company’s web site at www.impaxlabs.com.
This presentation will be archived on the Company’s web site for 30
days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing
partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward and Philadelphia
facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jul 2024 to Jul 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jul 2023 to Jul 2024